Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Swarm Intelligence in Drug Discovery Applications: Unlocking Deeper Insights on the Identification and Optimization of Potential Drug Candidates.

Drug design, development and therapy·2026
Same author

Learning to take it personally: Precision drug repurposing through patient-specific loss on knowledge graphs using Biobank data.

Journal of biomedical informatics·2026
Same author

Comparative evaluation of large language models in retrieving known and predicting novel drug combinations.

Journal of Alzheimer's disease : JAD·2026
Same author

Precision Drug Repurposing (PDR): Patient-level modeling and prediction combining foundational knowledge graph with biobank data.

Journal of biomedical informatics·2025
Same author

Tokenvizz: GraphRAG-Inspired Tokenization Tool for Genomic Data Discovery and Visualization.

bioRxiv : the preprint server for biology·2024
Same author

Systematic review and data synthesis on the treatment of sexual violence victimization by an intimate partner.

Journal of marital and family therapy·2023

相关实验视频

Updated: Sep 18, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.8K

KGiA:通过疾病意识知识图表增强来重新定位药物.

Çerağ Oğuztüzün1, Zhenxiang Gao2, Hui Li2

  • 1Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University, 10900 Euclid Ave, Cleveland, 44106, OH, USA; Department of Computer Science, Case Western Reserve University, 10900 Euclid Ave, Cleveland, 44106, OH, USA.

Journal of biomedical informatics
|June 22, 2025
PubMed
概括

本研究介绍了KGiA,这是一种使用反事实关系增强生物医学知识图 (KG) 的新方法. KGiA显著提高了药物重新定位的准确性,并确定了新的疾病候选药物.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.反事实关系是指反事实关系.药物重新定位是药物重新定位.微调的微调.基金会模型 基金会模型图形增强的图形增强方法图形拓学的图形拓学诱导性推理是一种诱导性推理.知识图是知识图.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

594

相关实验视频

Last Updated: Sep 18, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

594

科学领域:

  • 生物医学信息学 生物医学信息学
  • 计算生物学 计算生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 药物重新利用通过为现有药物找到新的用途来加速发展.
  • 生物医学知识图 (KG) 有助于药物重新使用,但由于不完整而受到限制.
  • 现有的KG方法难以将其推广到新的生物医学实体.

研究的目的:

  • 开发一种诱导式图形增强方法 (KGiA),用于增强药物重定位.
  • 为了使半诱导推理能够对看不见的生物医学实体进行概括.
  • 改进基于KG的药物重定向的性能和通用性.

主要方法:

  • 通过结合来自疾病特定拓模式的反事实关系,KGiA增强了知识图.
  • 该方法应用于一个大规模的生物医学KG (1.6M三倍,100K实体,30K疾病).
  • 半诱导推理允许对以前看不见的生物医学实体进行概括.

主要成果:

  • 在五个架构中,KGiA在平均互惠等级 (MRR) 中提高了24倍的概括性.
  • 拟议的方法高达32%的性能优于基于KG的最新药物重定向模型.
  • 包括阿尔茨海默病在内的案例研究表明,KGiA在识别新型重用药物候选者的潜力.

结论:

  • 增加知识图表与反事实关系可以改善基于KG的药物重定向.
  • 在药物发现方面,KGiA提供了一种有希望的方法来克服KG的不完整性.
  • 该方法提高了对现有药物的新疗法应用的识别能力.